Last reviewed · How we verify
NCT03563339: PPOD
Internet-delivered Postpartum Anxiety Prevention
NA trial testing P-POD in Postpartum Disorder in 19 participants. Completed in 13 December 2021.
13 December 2021
Quick facts
| Lead sponsor | West Virginia University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 19 |
| Start date | 8 April 2020 |
| Primary completion | 13 December 2021 |
| Estimated completion | 13 December 2021 |
| Sites | 1 location across United States |
Drugs / interventions tested
- P-POD
Conditions studied
- Postpartum Disorder — all drugs for Postpartum Disorder →
Sponsor
West Virginia University
Who can join
18 and older, female only, with Postpartum Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Postpartum anxiety disorders are the most prevalent postpartum psychiatric conditions. Up to 16% of mothers experience postpartum anxiety or related disorders, such as OCD. With respect to the investigator's own community, this means that up to 3,313 women in West Virginia may struggle with postpartum anxiety or OCD. Left untreated, perinatal anxiety and OCD are associated with numerous adverse outcomes, such as maternal depression, preterm birth, impaired fetal development, low birthweight, difficulty breastfeeding, anxiety in children, and interference with parent-infant bonding. Critically, anxiety is a risk factor for cardiovascular disease and substance use disorders, both significant West Virginia health disparities. Thus, there is a critical need to develop effective and scalable prevention programs to address postpartum anxiety and OCD. The purpose of this proposed community-engaged study is to develop and test the feasibility, usability, and acceptability of an Internet-delivered postpartum anxiety and OCD prevention program, called "Preventing Postpartum Onset Distress", or P-POD.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03563339
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Postpartum Disorder
Currently open trials in the same condition.
- NCT06460649 — Combined Effects Of Progressive Relaxation Techniques Along With Benson Relaxation Techniques · NA · recruiting
- NCT05676918 — Maternal Well-being in the Postnatal Stage · NA · recruiting
- NCT04873050 — Treatment to Regress to Normoglycemia in Women with a Recent History of GDM · Phase 4 · recruiting
Other West Virginia University trials
Trials by the same sponsor.
- NCT06686914 — The Effects of Cannabidiol on the Driving Performance of Healthy Adults by Dose and Sex · Phase 1 · recruiting
- NCT06791850 — Sustaining Home Heart Failure Palliative Care in Rural Appalachia · NA · recruiting
- NCT05705999 — Strengthening Tourette Treatment OPtions Using TMS to Improve CBIT, a Double-blind, Randomized, Controlled Study · NA · recruiting
- NCT05353244 — Effects of PrTMS on Performance · NA · withdrawn
- NCT06612788 — Exablate for LIFU Neuromodulation in Patients With Opioid Use Disorder (OUD) · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03563339 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by West Virginia University
- Last refreshed: 27 April 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03563339.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing